Your browser doesn't support javascript.
loading
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
van Schooten, Jelle; Schorcht, Anna; Farokhi, Elinaz; Umotoy, Jeffrey C; Gao, Hongmei; van den Kerkhof, Tom L G M; Dorning, Jessica; Rijkhold Meesters, Tim G; van der Woude, Patricia; Burger, Judith A; Bijl, Tom; Ghalaiyini, Riham; Torrents de la Peña, Alba; Turner, Hannah L; Labranche, Celia C; Stanfield, Robyn L; Sok, Devin; Schuitemaker, Hanneke; Montefiori, David C; Burton, Dennis R; Ozorowski, Gabriel; Seaman, Michael S; Wilson, Ian A; Sanders, Rogier W; Ward, Andrew B; van Gils, Marit J.
Afiliação
  • van Schooten J; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Schorcht A; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Farokhi E; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Umotoy JC; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Gao H; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
  • van den Kerkhof TLGM; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Dorning J; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Rijkhold Meesters TG; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • van der Woude P; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Burger JA; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bijl T; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Ghalaiyini R; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Torrents de la Peña A; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Labranche CC; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Stanfield RL; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Sok D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Schuitemaker H; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Montefiori DC; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.
  • Burton DR; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ozorowski G; International AIDS Vaccine Initiative, New York, New York, United States of America.
  • Seaman MS; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Wilson IA; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Sanders RW; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ward AB; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.
  • van Gils MJ; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.
PLoS Pathog ; 18(11): e1010945, 2022 11.
Article em En | MEDLINE | ID: mdl-36395347

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 / Soropositividade para HIV Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 / Soropositividade para HIV Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article